We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Apixaban
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='2p16' size='340' side='right' caption='Caption for this structure' scene=''> Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to tre...) |
|||
| Line 1: | Line 1: | ||
| - | <StructureSection load='2p16' size='340' side='right' caption=' | + | <StructureSection load='2p16' size='340' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban' scene=''> |
Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. | Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:03, 23 February 2023
| |||||||||||
